Smith & Nephew (SNN) Profit After Tax Growth (3y) (2012 - 2024)
Smith & Nephew (SNN) Profit After Tax Growth (3y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.39% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 62.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 3.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 30.85% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 3.38% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 6.53% |
| 10 | Smith & Nephew | 5.27 Bn | 4.69 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 4.30% |
| Dec 31, 2023 | 101.70% |
| Dec 31, 2022 | -18.94% |
| Dec 31, 2021 | -13.20% |
| Dec 31, 2020 | -27.83% |
| Dec 31, 2019 | 5.41% |
| Dec 31, 2018 | -6.03% |
| Dec 31, 2017 | -28.02% |
| Dec 31, 2016 | 17.03% |
| Dec 31, 2015 | 21.17% |
| Dec 31, 2014 | 53.40% |
| Sep 30, 2014 | -6.64% |
| Mar 31, 2014 | 4.09% |
| Dec 31, 2013 | -4.47% |
| Sep 28, 2013 | 9,538.86% |
| Jun 29, 2013 | 39.74% |
| Mar 31, 2013 | -3.48% |
| Dec 31, 2012 | 16.53% |
| Sep 29, 2012 | 10,162.78% |
| Jun 30, 2012 | 67.68% |